BDTX Insider Trading Activity and SEC Form 4 Filings
BDTX insider trading summary
No open-market insider purchases or sales of Black Diamond Therapeutics, Inc. (BDTX) have been reported on SEC Form 4 in the past 12 months.
Latest BDTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 19, 2025 | Biotech AG Bb | 10% Owner | Sell | $2.1M (1,000,000 @ $2.07) |
| Mar 19, 2025 | Growth N V Biotech | 10% Owner | Sell | $1.1M (500,000 @ $2.12) |
| Mar 19, 2025 | Growth N V Biotech | 10% Owner | Sell | $2.1M (1,000,000 @ $2.07) |
| Mar 19, 2025 | Growth N V Biotech | 10% Owner | Sell | $583K (300,000 @ $1.94) |
| Mar 19, 2025 | Growth N V Biotech | 10% Owner | Sell | $2.3M (1,000,000 @ $2.31) |
| Mar 19, 2025 | Biotech AG Bb | 10% Owner | Sell | $2.3M (1,000,000 @ $2.31) |
| Mar 19, 2025 | Growth N V Biotech | 10% Owner | Sell | $4.0M (2,000,000 @ $2.00) |
| Mar 19, 2025 | Biotech AG Bb | 10% Owner | Sell | $4.0M (2,000,000 @ $2.00) |
| Mar 19, 2025 | Biotech AG Bb | 10% Owner | Sell | $1.1M (500,000 @ $2.12) |
| Mar 19, 2025 | Biotech AG Bb | 10% Owner | Sell | $583K (300,000 @ $1.94) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.